Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Shares Outstanding (Weighted Average): 2017-2025

Historic Shares Outstanding (Weighted Average) for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $50.4 million.

  • Puma Biotechnology's Shares Outstanding (Weighted Average) rose 2.70% to $50.4 million in Q3 2025 from the same period last year, while for Dec 2024 it was $49.1 million, marking a year-over-year increase of 1.83%. This contributed to the annual value of $49.1 million for FY2024, which is 1.83% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Shares Outstanding (Weighted Average) is $50.4 million, which was up 1.48% from $49.6 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Shares Outstanding (Weighted Average) ranged from a high of $50.4 million in Q3 2025 and a low of $40.3 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $48.5 million, with a median of $48.2 million in 2024.
  • Data for Puma Biotechnology's Shares Outstanding (Weighted Average) shows a peak YoY grew of 12.84% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Shares Outstanding (Weighted Average) stood at $40.9 million in 2021, then increased by 11.63% to $45.6 million in 2022, then rose by 5.62% to $48.2 million in 2023, then climbed by 1.83% to $49.1 million in 2024, then increased by 2.70% to $50.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $50.4 million for Q3 2025, versus $49.6 million for Q2 2025 and $49.6 million for Q1 2025.